Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released today by the Centers for Disease Control and Prevention.

Israel initiated a national vaccination campaign using the Pfizer vaccine in December, prioritizing people over 60, health care workers and people with underlying medical conditions. By February, the ratio of COVID-19 patients aged 70 and older requiring mechanical ventilation declined 67% compared with that of patients under 50, the least vaccinated age group.

The authors said the findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 in Israel.

Related News Articles

Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…